DNLI

TAKE PARTIAL PROFITS ON PARKINSON’S AND ALZHEIMER’S BIOTECH DENALI THERAPEUTICS $DNLI

This post was just published on ZYX Buy Change Alert. DNLI was recently purchased at $18.  It is trading at $20.55 as of this writing.  Consider taking profits on 60% tranche in the zone of $20.18 to $22.48. Stop on the remaining $19.38 to $19.73 to protect the profits. What To Do

Read More

A NEW IDEA ON PARKINSON’S AND ALZHEIMER’S BIOTECH IPO DENALI THERAPEUTICS $DNLI

This post was just published on ZYX Buy Change Alert. Denali Therapeutics (DNLI) is a new IPO that is likely to start trading tomorrow.  The company is working specifically on Parkinson’s and Alzheimer’s.  This is a call to get up to 100% of the full core position size in the IPO.  Many

Read More

9 Winners. 9 Losers. Gold, Silver & AI Trade Zones.

9 Winners. 9 Losers.
Gold, Silver & AI Trade Zones.

A new market cycle is forming.

AI, Metals &
Memory Playbook

See where sophisticated investors are positioning across software, precious metals, and AI memory.

AI is power hungry. Investors will make a fortune from nuclear power for AI.
Get the list of 12 nuclear power stocks to grab your share of the profits.

Skip to content